Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk ― Never Judge a Book by Its Cover ―
Circulation Journal · 2023
DOI: 10.1253/circj.cj-23-0170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Journal, 2023. Verfasst von Raisuke Iijima. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Acute Coronary Syndrome. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University.
Zitieren
APA
Iijima, R. (2023). Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk ― Never Judge a Book by Its Cover ―. Circulation Journal. https://doi.org/10.1253/circj.cj-23-0170
Vancouver
Iijima R. Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk ― Never Judge a Book by Its Cover ―. Circulation Journal. 2023. doi:10.1253/circj.cj-23-0170
BibTeX
@article{Iijima2023,
author = {Iijima, Raisuke},
title = {Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk ― Never Judge a Book by Its Cover ―},
journal = {Circulation Journal},
year = {2023},
doi = {10.1253/circj.cj-23-0170}
}
EUVIMED